Drug registration guidance
This article was originally published in The Tan Sheet
Executive Summary
FDA will discontinue conventional mailing of annual re-registration forms to private label drug distributors and instead make them available online, according to draft guidance announced in May 15 Federal Register. Agency is developing software to allow electronic submission of drug registration/listing information. Until software is ready, Forms FDA 2656, 2657 and 2658 should be accessed online at www.fda.gov/cder/drls/registration_listing.htm
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning